MARKET

PHAT

PHAT

Phathom Pharmaceuticals, Inc.
NASDAQ
10.58
-0.21
-1.95%
After Hours: 10.58 0 0.00% 16:34 03/27 EDT
OPEN
11.26
PREV CLOSE
10.79
HIGH
11.48
LOW
10.44
VOLUME
1.50M
TURNOVER
--
52 WEEK HIGH
18.31
52 WEEK LOW
2.210
MARKET CAP
833.69M
P/E (TTM)
-3.4869
1D
5D
1M
3M
1Y
5Y
1D
Phathom upgraded at Barclays following pullback, Voquezna optimism
Seeking Alpha · 12h ago
BUZZ-U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services
Reuters · 14h ago
This Argan Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday
Benzinga · 16h ago
BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Phathom, Argan
Reuters · 16h ago
Phathom Pharmaceuticals Price Target Raised to $18.00/Share From $16.00 by Barclays
Dow Jones · 17h ago
Barclays Upgrades Phathom Pharmaceuticals to Overweight, Raises Price Target to $18
Benzinga · 17h ago
BUZZ- Barclays raises Phathom Pharmaceuticals to 'overweight'; shares rise
Reuters · 18h ago
PHATHOM PHARMACEUTICALS INC. <PHAT.O>: BARCLAYS RAISES TARGET PRICE TO $18 FROM $16
Reuters · 19h ago
More
About PHAT
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases. The Company’s product candidates include VOQUEZNA, VOQUEZNA TRIPLE PAK, and VOQUEZNA DUAL PAK. Its product candidate, VOQUEZNA, contains vonoprazan, an oral small molecule potassium-competitive acid blocker, or potassium-competitive acid blocker (PCAB). PCABs are a novel class of medicines that block acid secretion in the stomach. Vonoprazan has also demonstrated clinical benefits in the treatment of erosive gastroesophageal reflux disease (erosive GERD), and in combination with antibiotics for the treatment of Helicobacter pylori (H. pylori) infection. GERD and H. pylori infection are two of the most common acid-related GI diseases. GERD is a disease that develops when the reflux of acidic stomach contents causes troublesome symptoms and/or complications. H. pylori is a bacterial pathogen.

Webull offers Phathom Pharmaceuticals Inc stock information, including NASDAQ: PHAT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHAT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHAT stock methods without spending real money on the virtual paper trading platform.